antares pharma inc
(ATRS:Consolidated Issue listed on NASDAQ Capital Market)
Paul K. Wotton Ph.D.
Chief Executive Officer and President, Advanced Cell Technology Inc.
|Age||Total Calculated Compensation||This person is connected to 17 board members in 1 different organizations across 5 different industries.|
See Board Relationships
Dr. Paul K. Wotton, Ph.D. has been Chief Executive Officer and President at Advanced Cell Technology Inc. since June 24, 2014. Dr. Wotton served as the Chief Executive Officer of Antares Pharma Inc. since October 2008 until June 2014 and served as its President since July 2008 until June 2014. Dr. Wotton served as the Chief Executive Officer and President of Topigen Pharmaceuticals Inc. until March 2008. He served as Chief Operating Officer of Antares Pharma Inc. from ...
100 Princeton SouthPhone: 609-359-3020
Ewing, New Jersey 08628
Board Members Memberships*
Former Chief Executive Officer, President and Executive Director
Former Chief Executive Officer, President and Director
University Of London
Kingston Business School
Annual Compensation*There is no Annual Compensation data available.
Stock Options*There is no Stock Options data available.
Total Compensation*There is no Total Compensation data available.
|Michael D. West Ph.D.||Chief Executive Officer, President and Director|
|Marc H. Hedrick M.D.||Chief Executive Officer, President, Director and Member of Executive Committee|
Cytori Therapeutics, Inc.
|Robin L. Smith M.D., MBA,Ro||Executive Chairman and Chief Executive Officer|
|David M. Pernock||Chairman, Chief Executive Officer and President|
Fibrocell Science, Inc.
|I. Richard Garr J.D.||Co-Founder, Chief Executive Officer, President, Chief Financial Officer, Principal Accounting Officer, General Counsel and Director|
|$651.2K||Compensation as of Fiscal Year 2013.|